Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21771568

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2011 Aug
First author
Morgan GJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2011 Aug;12(8):711-2. doi: 10.1016/S1470-2045(11)70178-4.
    note
    Source null
    related pmid
    21771569
    relationship
    Comment in

Authors and identifiers

  1. name
    Morgan GJ
    type
    Author
  2. name
    Child JA
    type
    Author
  3. name
    Gregory WM
    type
    Author
  4. name
    Szubert AJ
    type
    Author
  5. name
    Cocks K
    type
    Author
  6. name
    Bell SE
    type
    Author
  7. name
    Navarro-Coy N
    type
    Author
  8. name
    Drayson MT
    type
    Author
  9. name
    Owen RG
    type
    Author
  10. name
    Feyler S
    type
    Author
  11. name
    Ashcroft AJ
    type
    Author
  12. name
    Ross FM
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Morgan GJ
    type
    Author
  2. name
    Child JA
    type
    Author
  3. name
    Gregory WM
    type
    Author
  4. name
    Szubert AJ
    type
    Author
  5. name
    Cocks K
    type
    Author
  6. name
    Bell SE
    type
    Author
  7. name
    Navarro-Coy N
    type
    Author
  8. name
    Drayson MT
    type
    Author
  9. name
    Owen RG
    type
    Author
  10. name
    Feyler S
    type
    Author
  11. name
    Ashcroft AJ
    type
    Author
  12. name
    Ross FM
    type
    Author
bibliography ids
  1. nci-bib-dd18144da7c0a8c0122eb432
book metadata
content sha256
e10be6c03936663ade52946a15b5f890795b142e537177b5d18ab14c0a234cad
document type
citation
dois
  1. 10.1016/S1470-2045(11)70157-7
electronic publication date
display
2011 Jul 21
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:21771568
immutable id
pubmed:21771568@e10be6c03936663ade52946a15b5f890795b142e537177b5d18ab14c0a234cad
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
8
name
The Lancet. Oncology
nlm unique id
100957246
pages
743-52
volume
12
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2011 Aug;12(8):711-2. doi: 10.1016/S1470-2045(11)70178-4.
    note
    Source null
    related pmid
    21771569
    relationship
    Comment in
outcomes validated
false
pmid
21771568
provenance
batch id
2529ef2eca926738ab13
provider
NCBI PubMed ESummary
record sha256
47d13cc10ffb28beb12d14a1de2e3ca9dace378849db6d259233e4b713ed8a41
response sha256
9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
retrieved at
2026-09-09T23:46:42.856296+00:00
publication date
display
2011 Aug
precision
month
year
2011
publication types
  1. Comparative Study
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21771568/
title
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial.

Preserved source evidence · Not medical advice